2025-05-05 - Analysis Report
## Natera Inc. (NTRA) Stock Review

**0. Key Figures Summary:**

* **Cumulative Return (NTRA):** 136.68%
* **Cumulative Return (VOO):** 82.77%
* **Return Difference:** 53.9%
* **Relative Divergence:** 15.3% (Indicates NTRA's performance is in the higher range relative to its historical performance compared to VOO)
* **Current Price:** $156.66


**1. Performance Comparison & Company Overview:**

Natera Inc. is a company focused on genetic testing and diagnostics.  (A more detailed description would require additional information.)

NTRA significantly outperformed the S&P 500 (VOO) over the measured period, with a cumulative return 53.9 percentage points higher.  The relative divergence of 15.3% suggests that this outperformance is relatively strong compared to its historical performance against VOO.  However, the provided data does not show the full historical context of the price movements, so extreme caution is needed when interpreting the relative divergence.

**Alpha and Beta Analysis:**

The provided data shows significant volatility in both CAGR and Alpha across the years.  While some periods show high positive alpha (outperformance), others show substantial negative alpha and negative CAGR, indicating significant underperformance compared to the market. The beta fluctuates, suggesting varying sensitivities to market movements.  Note that the market cap (Cap(B)) shows significant growth over the period.

| Year       | CAGR     | MDD      | Alpha   | Beta | Cap(B) |
|------------|----------|----------|---------|-------|--------|
| 2015-2017  | -6.0%    | 62.4%    | -0.1    | 1.2   |        |
| 2016-2018  | 29.0%    | 80.1%    | 0.0     | 1.9   |        |
| 2017-2019  | 159.0%   | 80.1%    | 1.3     | 4.6   |        |
| 2018-2020  | 530.0%   | 80.1%    | 0.7     | 13.5  |        |
| 2019-2021  | 355.0%   | 62.9%    | 0.3     | 12.7  |        |
| 2020-2022  | -119.0%  | 62.9%    | 0.3     | 5.5   |        |
| 2021-2023  | -482.0%  | 69.9%    | 1.3     | 8.5   |        |
| 2022-2024  | -75.0%   | 70.6%    | 1.3     | 21.5  |        |
| 2023-2025  | 85.0%    | 72.8%    | 0.9     | 21.3  |        |


**2. Recent Price Movement:**

* **Closing Price:** $156.66
* **5-Day Moving Average:** $153.37
* **20-Day Moving Average:** $147.83
* **60-Day Moving Average:** $151.79

The price is above all three moving averages, suggesting a short-term uptrend.  The recent price increase of $3.5 (from $151.36) is noticeable and would be considered a sharp rise (potentially a result of a recent news event).


**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.3776 (Medium Risk)
* **RSI:** 61.18 (Slightly above neutral; not overbought)
* **PPO:** 0.6972 (Positive; bullish signal)
* **20-Day Relative Divergence Change:** -0.1 (Short-term bearish signal)
* **Expected Return (2+ years):** 97.2% (Significant outperformance of VOO anticipated over the long term)

The combination of indicators suggests a mixed outlook, with some bullish and some bearish signals.  The high expected return should be viewed cautiously, as it relies on the continuation of a favorable environment and may not reflect the considerable volatility seen in the past.


**4. Recent Earnings Analysis:**

The company has consistently reported negative EPS over the past few quarters, indicating losses.  Revenue is growing, but at a slower pace, and is not yet translating to profitability.  The duplicate entry for 2024-11-12 needs clarification.

| Date       | EPS    | Revenue     |
|------------|--------|-------------|
| 2024-11-12 | -$0.26 | $0.44 B     |
| 2024-08-09 | -$0.3  | $0.41 B     |
| 2024-05-10 | -$0.56 | $0.37 B     |
| 2023-11-09 | -$0.95 | $0.27 B     |
| 2024-11-12 | -$0.95 | $0.27 B     |


**5. Financial Information:**

Revenue is steadily increasing, indicating growth. Profit margins are also improving, though remain to be seen as sustainable given the persistent negative EPS.  Equity is growing, but the ROE is consistently negative, indicating that the company is not generating returns on its equity.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $0.48B   | 62.94%        |
| 2024-09-30 | $0.44B   | 61.79%        |
| 2024-06-30 | $0.41B   | 58.83%        |
| 2024-03-31 | $0.37B   | 56.72%        |
| 2023-12-31 | $0.31B   | 51.38%        |

**Capital and Profitability:**

| Quarter     | Equity   | ROE          |
|-------------|----------|--------------|
| 2024-12-31 | $1.20B   | -4.50%       |
| 2024-09-30 | $0.88B   | -3.60%       |
| 2024-06-30 | $0.84B   | -4.48%       |
| 2024-03-31 | $0.79B   | -8.51%       |
| 2023-12-31 | $0.77B   | -10.20%      |


**6. Overall Analysis:**

NTRA shows significant potential,  outperforming the S&P 500 considerably over the analyzed period.  However, this outperformance is characterized by considerable volatility.  The company is growing its revenue and improving its profit margins, but it's crucial to note the persistent negative EPS and ROE.  While the long-term expected return is high,  the high risk and the negative earnings raise considerable concerns.  Further investigation into the underlying drivers of revenue growth, the reasons for negative profitability, and the potential for future profitability are essential before making any investment decisions.  The recent price surge warrants caution,  as it may be unsustainable without underlying fundamental improvements.  A deep dive into the company's financial statements and future growth prospects is highly recommended.
